Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Anecortave Acetate in Wet AMD
NCT00065728Phase 3Terminated
- Sponsor
- Alcon Inc.
- Start
- Jun 2003
- Primary completion
- Oct 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of anecortave in exudative age-related macular degeneration, sponsored by Alcon Inc.. Started Jun 2003; status: terminated.
02
Drugs
anecortave
03
Conditions
exudative age-related macular degeneration
Beyond the preview
Go deeper on NCT00065728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00065728.